tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

MTVA Stock Latest News

MetaVia Seeks Extension to Regain Nasdaq Compliance
Company AnnouncementsMetaVia Seeks Extension to Regain Nasdaq Compliance
5d ago
8K
MTVA
VTI ETF Daily Report—11/19/2025
PremiumMarket News
VTI ETF Daily Report—11/19/2025
12d ago
LXP
VTI
What’s Moving VTI ETF? Daily Snapshot — 11/18/2025
PremiumMarket News
What’s Moving VTI ETF? Daily Snapshot — 11/18/2025
13d ago
LXP
VTI
VTI ETF Daily Update—11/17/2025
PremiumMarket News
VTI ETF Daily Update—11/17/2025
14d ago
LXP
VTI
VTI ETF Daily Report—11/14/2025
PremiumMarket News
VTI ETF Daily Report—11/14/2025
17d ago
DDS
LXP
Vanguard Total Stock Market ETF (VTI) Daily Snapshot — 11/13/25
PremiumMarket NewsVanguard Total Stock Market ETF (VTI) Daily Snapshot — 11/13/25
18d ago
LXP
VTI
Daily VTI ETF Snapshot: Insights for Investors—11/12/2025
Premium
Market News
Daily VTI ETF Snapshot: Insights for Investors—11/12/2025
19d ago
LVO
LXP
Daily VTI ETF Snapshot: Insights for Investors – 11/11/2025
Premium
Market News
Daily VTI ETF Snapshot: Insights for Investors – 11/11/2025
20d ago
LVO
VTI
MetaVia Inc. Reports Q3 2025 Financial Results
PremiumCompany Announcements
MetaVia Inc. Reports Q3 2025 Financial Results
20d ago
MTVA
MetaVia’s Strategic Positioning and Promising Drug Candidates Drive Buy Rating
PremiumRatings
MetaVia’s Strategic Positioning and Promising Drug Candidates Drive Buy Rating
21d ago
MTVA
MetaVia Announces Positive Phase 2a Trial Results
PremiumCompany Announcements
MetaVia Announces Positive Phase 2a Trial Results
24d ago
8K
MTVA
MetaVia annunces presentation of data from Phase 2 clinical trail of vanoglipel
PremiumThe Fly
MetaVia annunces presentation of data from Phase 2 clinical trail of vanoglipel
24d ago
MTVA
MetaVia Releases Updated Corporate Presentation on Trials
PremiumCompany AnnouncementsMetaVia Releases Updated Corporate Presentation on Trials
25d ago
8K
MTVA
MetaVia reports Q3 EPS (14c), consensus (25c)
Premium
The Fly
MetaVia reports Q3 EPS (14c), consensus (25c)
25d ago
MTVA
Metavia Inc. Advances Obesity Treatment with New Clinical Study
Premium
Company Announcements
Metavia Inc. Advances Obesity Treatment with New Clinical Study
1M ago
MTVA
MetaVia assumed with a Buy at H.C. Wainwright
PremiumThe Fly
MetaVia assumed with a Buy at H.C. Wainwright
3M ago
MTVA
MetaVia Inc. Reports Q2 2025 Financial Results and Strategic Progress
PremiumCompany Announcements
MetaVia Inc. Reports Q2 2025 Financial Results and Strategic Progress
4M ago
MTVA
Optimistic Buy Rating for MetaVia Driven by Promising Obesity Drug Developments and Strategic Collaborations
PremiumRatings
Optimistic Buy Rating for MetaVia Driven by Promising Obesity Drug Developments and Strategic Collaborations
4M ago
MTVA
MetaVia Highlights Clinical Trials and Future Plans
PremiumCompany Announcements
MetaVia Highlights Clinical Trials and Future Plans
4M ago
8K
MTVA
MetaVia Extends Phase 1 Trial for Obesity Drug
PremiumCompany AnnouncementsMetaVia Extends Phase 1 Trial for Obesity Drug
4M ago
8K
MTVA
MetaVia extends Phase 1 clinical trial of DA-1726
Premium
The Fly
MetaVia extends Phase 1 clinical trial of DA-1726
4M ago
MTVA
MetaVia Partners with Syntekabio for DA-1241 Research
Premium
Company Announcements
MetaVia Partners with Syntekabio for DA-1241 Research
4M ago
8K
MTVA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >